Altimmune (ALT) said Monday its board has named Jerry Durso its chair, effective Aug. 12.
Durso succeeds Mitchel Sayare who will continue to remain an independent director, the company said.
Durso was previously Intercept Pharmaceuticals' CEO, Altimmune said.